<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2023-02-23T14:57:25Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7555662" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7555662</identifier>
        <datestamp>2020-10-19</datestamp>
        <setSpec>ijms</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
              <journal-id journal-id-type="publisher-id">ijms</journal-id>
              <journal-title-group>
                <journal-title>International Journal of Molecular Sciences</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1422-0067</issn>
              <publisher>
                <publisher-name>MDPI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7555662</article-id>
              <article-id pub-id-type="pmcid">PMC7555662</article-id>
              <article-id pub-id-type="pmc-uid">7555662</article-id>
              <article-id pub-id-type="pmid">32971944</article-id>
              <article-id pub-id-type="doi">10.3390/ijms21186971</article-id>
              <article-id pub-id-type="publisher-id">ijms-21-06971</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>4-Acetylantroquinonol B Inhibits Osteoclastogenesis by Inhibiting the Autophagy Pathway in a Simulated Microgravity Model</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8389-6599</contrib-id>
                  <name>
                    <surname>Wu</surname>
                    <given-names>Chia-Hsin</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-21-06971">1</xref>
                  <xref ref-type="author-notes" rid="fn1-ijms-21-06971">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ou</surname>
                    <given-names>Ching-Huei</given-names>
                  </name>
                  <xref ref-type="aff" rid="af2-ijms-21-06971">2</xref>
                  <xref ref-type="author-notes" rid="fn1-ijms-21-06971">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3673-9870</contrib-id>
                  <name>
                    <surname>Yen</surname>
                    <given-names>I-Chuan</given-names>
                  </name>
                  <xref ref-type="aff" rid="af3-ijms-21-06971">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4713-6410</contrib-id>
                  <name>
                    <surname>Lee</surname>
                    <given-names>Shih-Yu</given-names>
                  </name>
                  <xref ref-type="aff" rid="af1-ijms-21-06971">1</xref>
                  <xref rid="c1-ijms-21-06971" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="af1-ijms-21-06971"><label>1</label>Graduate Institute of Aerospace and Undersea Medicine, National Defense Medical Center, Taipei 11490, Taiwan; <email>chiahsin.ch.wu@gmail.com</email></aff>
              <aff id="af2-ijms-21-06971"><label>2</label>Department of Anesthesiology, Cheng-Hsin General Hospital, Taipei 11220, Taiwan; <email>o940209@yahoo.com.tw</email></aff>
              <aff id="af3-ijms-21-06971"><label>3</label>School of Pharmacy, National Defense Medical Center, Taipei 11490, Taiwan; <email>yenichuan@mail.ndmctsgh.edu.tw</email></aff>
              <author-notes>
                <corresp id="c1-ijms-21-06971"><label>*</label>Correspondence: <email>leeshihyuno1@mail.ndmctsgh.edu.tw</email>; Tel.: +886-2-87923100; Fax: +886-2-87927380</corresp>
                <fn id="fn1-ijms-21-06971">
                  <label>†</label>
                  <p>These authors contributed equally to this work.</p>
                </fn>
              </author-notes>
              <pub-date pub-type="epub">
                <day>22</day>
                <month>9</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>9</month>
                <year>2020</year>
              </pub-date>
              <volume>21</volume>
              <issue>18</issue>
              <elocation-id>6971</elocation-id>
              <history>
                <date date-type="received">
                  <day>26</day>
                  <month>8</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>18</day>
                  <month>9</month>
                  <year>2020</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2020 by the authors.</copyright-statement>
                <copyright-year>2020</copyright-year>
                <license license-type="open-access">
                  <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <p>Astronauts suffer from 1–2% bone loss per month during space missions. Targeting osteoclast differentiation has been regarded as a promising strategy to prevent osteoporosis in microgravity (μXg). 4-acetylantroquinonol B (4-AAQB), a ubiquinone from <italic>Antrodia cinnamomea</italic>, has shown anti-inflammatory and anti-hepatoma activities. However, the effect of 4-AAQB on μXg-induced osteoclastogenesis remains unclear. In this study, we aimed to explore the mechanistic impact of 4-AAQB on osteoclast formation under μXg conditions. The monocyte/macrophage-like cell line RAW264.7 was exposed to simulated μXg (Rotary Cell Culture System; Synthecon, Houston, TX, USA) for 24 h and then treated with 4-AAQB or alendronate (ALN) and osteoclast differentiation factor receptor activator of nuclear factor kappa-B ligand (RANKL). Osteoclastogenesis, bone resorption activity, and osteoclast differentiation-related signaling pathways were analyzed using tartrate-resistant acid phosphatase (TRAP) staining, actin ring fluorescent staining, bone resorption, and western blotting assays. Based on the results of TRAP staining, actin ring staining, and bone resorption assays, we found that 4-AAQB significantly inhibited μXg-induced osteoclast differentiation. The critical regulators of osteoclast differentiation, including nuclear factor of activated T-cells cytoplasmic 1 (NFATc1), c-Fos, and dendritic cell-specific transmembrane protein (DC-STAMP), were consistently decreased. Meanwhile, osteoclast apoptosis and cell cycle arrest were also observed along with autophagy suppression. Interestingly, the autophagy inhibitors 3-methyladenine (3-MA) and chloroquine (CQ) showed similar effects to 4-AAQB. In conclusion, we suggest that 4-AAQB may serve as a potential agent against μXg-induced osteoclast formation.</p>
              </abstract>
              <kwd-group>
                <kwd>4-acetylantroquinonol B</kwd>
                <kwd>microgravity</kwd>
                <kwd>osteoclastogenesis</kwd>
                <kwd>autophagy</kwd>
              </kwd-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="sec1-ijms-21-06971">
              <title>1. Introduction</title>
              <p>In a space environment, several risk factors threaten the health of astronauts, including variations in gravity and radiation [<xref rid="B1-ijms-21-06971" ref-type="bibr">1</xref>]. Astronauts face multiple challenges in a microgravity (µXg) environment, including deconditioning of the cardiovascular system, suppression of immune function, and imbalance of bone metabolism during spaceflights [<xref rid="B2-ijms-21-06971" ref-type="bibr">2</xref>,<xref rid="B3-ijms-21-06971" ref-type="bibr">3</xref>,<xref rid="B4-ijms-21-06971" ref-type="bibr">4</xref>,<xref rid="B5-ijms-21-06971" ref-type="bibr">5</xref>,<xref rid="B6-ijms-21-06971" ref-type="bibr">6</xref>]. Among these, skeletal metabolism-related problems pose a ubiquitous concern among space travelers. One long-term study found that astronauts lose an average bone density of 11% over a 4–6 month mission [<xref rid="B2-ijms-21-06971" ref-type="bibr">2</xref>]. In general, astronauts experience decreases of 1% muscle mass and 1.8–2% bone density per month [<xref rid="B3-ijms-21-06971" ref-type="bibr">3</xref>]. Although resistance exercises promote muscle mass maintenance, bone loss remains a problem for astronauts due to an imbalance between bone formation and bone resorption. Studies have reported that exposure to a μXg environment results in decreased osteoblast formation [<xref rid="B7-ijms-21-06971" ref-type="bibr">7</xref>] and increased osteoclast differentiation [<xref rid="B8-ijms-21-06971" ref-type="bibr">8</xref>]. Therefore, targeting osteoclastogenesis has been regarded as a promising strategy to prevent osteoporosis in μXg conditions [<xref rid="B8-ijms-21-06971" ref-type="bibr">8</xref>,<xref rid="B9-ijms-21-06971" ref-type="bibr">9</xref>].</p>
              <p>Osteoclasts originate from the monocyte-macrophage lineage, and many factors are involved in the process of osteoclast differentiation. c-Fos and nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) are two important factors involved in osteoclast differentiation [<xref rid="B10-ijms-21-06971" ref-type="bibr">10</xref>,<xref rid="B11-ijms-21-06971" ref-type="bibr">11</xref>]. Dendritic cell-specific transmembrane protein (DC-STAMP) also participates in osteoclast differentiation and is related to cell-cell fusion [<xref rid="B12-ijms-21-06971" ref-type="bibr">12</xref>,<xref rid="B13-ijms-21-06971" ref-type="bibr">13</xref>]. Two inflammatory related pathways, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinases (MAPKs), regulate osteoclast differentiation and function [<xref rid="B14-ijms-21-06971" ref-type="bibr">14</xref>]. At present, the methods to alleviate overactivated osteoclasts include inhibiting osteoclastogenesis, inducing cell apoptosis, and inhibiting osteoclast resorption activities [<xref rid="B15-ijms-21-06971" ref-type="bibr">15</xref>]. Bisphosphonate, a current treatment for osteoporosis, inhibits osteoclast formation and function by activating the caspase-3 and caspase-9 apoptosis signaling pathways [<xref rid="B16-ijms-21-06971" ref-type="bibr">16</xref>,<xref rid="B17-ijms-21-06971" ref-type="bibr">17</xref>]. Autophagy is also involved in osteoclastogenesis. Overexpression of Beclin-1 has been observed to suppress osteoclast precursor apoptosis [<xref rid="B18-ijms-21-06971" ref-type="bibr">18</xref>] while autophagy inhibitors consistently suppress osteoclastogenesis [<xref rid="B19-ijms-21-06971" ref-type="bibr">19</xref>].</p>
              <p>Current bone loss prevention methods during space missions involve exercise and drug intervention [<xref rid="B20-ijms-21-06971" ref-type="bibr">20</xref>,<xref rid="B21-ijms-21-06971" ref-type="bibr">21</xref>,<xref rid="B22-ijms-21-06971" ref-type="bibr">22</xref>]; however, a more effective mechanism needs to be developed. 4-acetylantroquinonol B (4-AAQB), a ubiquinone from <italic>Antrodia cinnamomea</italic>, has been found to possess anti-inflammatory [<xref rid="B23-ijms-21-06971" ref-type="bibr">23</xref>,<xref rid="B24-ijms-21-06971" ref-type="bibr">24</xref>], antioxidant [<xref rid="B25-ijms-21-06971" ref-type="bibr">25</xref>], and anti-hepatoma properties [<xref rid="B24-ijms-21-06971" ref-type="bibr">24</xref>,<xref rid="B26-ijms-21-06971" ref-type="bibr">26</xref>]. A recent study showed that 4-AAQB suppresses autophagic flux through the PI3K signaling pathway in epithelial cancer cells [<xref rid="B27-ijms-21-06971" ref-type="bibr">27</xref>]. It is well known that the inflammatory and autophagy signaling pathways are highly associated with osteoclastogenesis [<xref rid="B18-ijms-21-06971" ref-type="bibr">18</xref>,<xref rid="B28-ijms-21-06971" ref-type="bibr">28</xref>]. These findings imply a role of 4-AAQB in osteoclastogenesis regulation. This study aimed to explore the mechanistic impact of 4-AAQB on osteoclast formation under μXg conditions.</p>
            </sec>
            <sec id="sec2-ijms-21-06971">
              <title>2. Materials and Methods</title>
              <sec id="sec2dot1-ijms-21-06971">
                <title>2.1. 4-AAQB</title>
                <p>4-AAQB was prepared as previously described. Briefly, dried <italic>A. cinnamomea</italic> mycelium was extracted with 95% alcohol, and the extract was successively partitioned with dichloromethane and water. The dichloromethane-soluble fraction (60 g from 1305.3 g of mycelium) was subjected to column chromatography and high-performance liquid chromatography separation as described previously [<xref rid="B29-ijms-21-06971" ref-type="bibr">29</xref>,<xref rid="B30-ijms-21-06971" ref-type="bibr">30</xref>].</p>
              </sec>
              <sec id="sec2dot2-ijms-21-06971">
                <title>2.2. Cell Culture</title>
                <p>The RAW264.7 cell line was purchased from the American Type Culture Collection (Manassas, VA, USA). RAW264.7 cells are widely used for studying osteoclastogenesis [<xref rid="B9-ijms-21-06971" ref-type="bibr">9</xref>,<xref rid="B31-ijms-21-06971" ref-type="bibr">31</xref>,<xref rid="B32-ijms-21-06971" ref-type="bibr">32</xref>]. The cells were maintained at 37 °C in an atmosphere of 5% CO<sub>2</sub> in Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum. Receptor activator of nuclear factor-κB ligand (RANKL; 100 ng/mL) was added to induce osteoclast differentiation.</p>
              </sec>
              <sec id="sec2dot3-ijms-21-06971">
                <title>2.3. Cell Viability Assay</title>
                <p>Cell viability was determined using the alamarBlue Cell Viability assay kit (Invitrogen™, Thermo Fisher Scientific Inc., Waltham, MA, USA) as previously described [<xref rid="B33-ijms-21-06971" ref-type="bibr">33</xref>]. Briefly, the cells (1 × 10<sup>4</sup> cells/well) were seeded into 96-well plates for 24 h. After treatment with 4-AAQB or alendronate (ALN) for 72 h, an alamarBlue solution was added for 2 h at 37 °C. The absorbance was measured at 570/630 nm using a spectrophotometer (Spectra Max 190; Molecular Devices, Sunnyvale, CA, USA).</p>
              </sec>
              <sec id="sec2dot4-ijms-21-06971">
                <title>2.4. Rotary Cell Culture System (RCCS)</title>
                <p>The RCCS (Synthecon, Houston, TX, USA) is a system that provides a low-shear μXg-like environment. The rotary speed of the RCCS was set at 12 rpm, and the cells were incubated in the RCCS for 24 h to simulate μXg (0.004 Xg) or normal-gravity (v-Xg), which rotated around a vertical or horizontal axis [<xref rid="B9-ijms-21-06971" ref-type="bibr">9</xref>].</p>
              </sec>
              <sec id="sec2dot5-ijms-21-06971">
                <title>2.5. Tartrate-Resistant Acid Phosphatase (Trap) Staining</title>
                <p>The cells were fixed with fixation solution supplemented with 10% formaldehyde for 10 min at 25 °C and then stained with TRAP solution (Sigma-Aldrich, St. Louis, MO, USA) for 20 min [<xref rid="B34-ijms-21-06971" ref-type="bibr">34</xref>]. Images were visualized with a light microscope (DMi8; Leica Microsystems, Wetzlar, Germany). The number of TRAP (+) cells/well and area of TRAP (+) cells (%) were measured using ImageJ software version 1.50a (National Institutes of Health [NIH], Bethesda, MD, USA).</p>
              </sec>
              <sec id="sec2dot6-ijms-21-06971">
                <title>2.6. Actin Ring Immunofluorescence</title>
                <p>The cells were fixed with 4% methanol-free formaldehyde for 10 min at 25 °C. Later, the cells were stained with Alexa Fluor<sup>®</sup> 488 Phalloidin (Cell Signaling Technology, Danvers, MA, USA) in the dark for 15 min at 25 °C. Then, the cells were washed and stained with nuclear 4′,6-diamidino-2-phenylindole dye (Cell Signaling Technology) in the dark for 5 min at 25 °C [<xref rid="B35-ijms-21-06971" ref-type="bibr">35</xref>]. Images were visualized with a light microscope (DMi8; Leica Microsystems). The number of actin rings/well was measured using ImageJ software version 1.50a (NIH).</p>
              </sec>
              <sec id="sec2dot7-ijms-21-06971">
                <title>2.7. Osteo Assay</title>
                <p>After being cultured in Corning Osteo Assay (Corning, Inc., Corning, NY, USA) 96-well plates for 120 h, the cells were incubated with the bleach solution for 5 min at room temperature. The plates were washed with distilled water twice and dried at room temperature for 5 h [<xref rid="B36-ijms-21-06971" ref-type="bibr">36</xref>]. Images were visualized with a light microscope (DMi8; Leica Microsystems). The percentage of bone resorption area was measured using ImageJ software version 1.50a (NIH).</p>
              </sec>
              <sec id="sec2dot8-ijms-21-06971">
                <title>2.8. Western Blotting</title>
                <p>Immunoblotting was performed using primary antibodies against cyclin D3 (BD Biosciences, San Diego, CA, USA), Atg 5, Atg 7, caspase-9, caspase-8, caspase-3, c-Fos, NFATc1, PARP (Cell Signaling Technology), cyclin E1, p21 (GeneTex, Irvine, CA, USA), DC-STAMP (Merck, Kenilworth, NJ, USA), β-actin, LC3B, and p62 (Proteintech, Chicago, IL, USA). The blots were developed with an enhanced chemiluminescence kit (Amersham Biosciences, Buckinghamshire, UK) and measured using a luminescent image analyzer (LAS-3000; Fuji Photo Film Co., Ltd., Tokyo, Japan) [<xref rid="B37-ijms-21-06971" ref-type="bibr">37</xref>].</p>
              </sec>
              <sec id="sec2dot9-ijms-21-06971">
                <title>2.9. Statistical Analysis</title>
                <p>All data are presented as the mean ± standard error of the mean. Significant differences between the means of two groups were determined with a <italic>t</italic>-test using GraphPad Prism software version 7.0 (GraphPad Software, San Diego, CA, USA). Statistical significance was considered at <italic>p</italic> &lt; 0.05.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec3-ijms-21-06971">
              <title>3. Results</title>
              <sec id="sec3dot1-ijms-21-06971">
                <title>3.1. 4-AAQB Cytotoxicity under Both v-Xg And µXg Conditions</title>
                <p><xref ref-type="fig" rid="ijms-21-06971-f001">Figure 1</xref>A shows the chemical structure of 4-AAQB. 4-AAQB and ALN, a positive control, did not alter cell viability in either v-Xg or µXg conditions (<xref ref-type="fig" rid="ijms-21-06971-f001">Figure 1</xref>B).</p>
              </sec>
              <sec id="sec3dot2-ijms-21-06971">
                <title>3.2. 4-AAQB Effects on RANKL-Induced Osteoclast Formation and Resorption Ability in Both v-Xg and µXg Conditions</title>
                <p>To examine the effects of 4-AAQB on osteoclast formation, TRAP staining was conducted. Our results showed that 4-AAQB eliminated both the number and area of TRAP (+) osteoclasts (<xref ref-type="fig" rid="ijms-21-06971-f002">Figure 2</xref>A–D) under both v-Xg and µXg conditions. The number of actin rings was also consistently decreased by 4-AAQB (<xref ref-type="fig" rid="ijms-21-06971-f002">Figure 2</xref>E–G). We further assessed the effects of 4-AAQB on osteoclast resorption activity using an osteo assay. 4-AAQB significantly decreased osteoclast resorption activity as expected (<xref ref-type="fig" rid="ijms-21-06971-f003">Figure 3</xref>A–C). Based on these findings, 4-AAQB attenuates RANKL-induced osteoclast formation and resorption activity. These findings indicate that 4-AAQB efficiently attenuates osteoclast formation in both v-Xg and µXg conditions. Interestingly, 4-AAQB displayed greater efficacy in µXg than in v-Xg.</p>
              </sec>
              <sec id="sec3dot3-ijms-21-06971">
                <title>3.3. Inhibition of Essential Osteoclast Differentiation Pathways by 4-AAQB, Especially in µXg Conditions</title>
                <p>To confirm the inhibitory effects of 4-AAQB on osteoclastogenesis, the protein levels of c-Fos, NFATc1, and DC-STAMP were analyzed by western blotting. We showed that the NFATc1, c-Fos, and DC-STAMP protein levels were decreased by 4-AAQB in both v-Xg (<xref ref-type="fig" rid="ijms-21-06971-f004">Figure 4</xref>A–D) and µXg conditions (<xref ref-type="fig" rid="ijms-21-06971-f004">Figure 4</xref>E–H). Thus, 4-AAQB appears to successfully attenuate the osteoclastogenesis signaling pathway, especially under µXg conditions. In µXg, 4-AAQB not only alleviates osteoclast formation and resorption activities but also suppresses the key regulators of osteoclast differentiation and cell-cell fusion.</p>
              </sec>
              <sec id="sec3dot4-ijms-21-06971">
                <title>3.4. 4-AAQB Effects on Osteoclast Apoptosis and Cell Cycle Arrest under μXg Conditions</title>
                <p>Cell apoptosis and cell cycle-related proteins were further analyzed under μXg conditions. We found that 4-AAQB increased cleaved caspase-3 and cleaved PARP but decreased cleaved caspase-8 protein levels (<xref ref-type="fig" rid="ijms-21-06971-f005">Figure 5</xref>A–E). Furthermore, the protein levels of p21, cyclin D3, and cyclin E1 were suppressed by 4-AAQB (<xref ref-type="fig" rid="ijms-21-06971-f005">Figure 5</xref>F–J). These findings indicate that 4-AAQB not only promotes cell apoptosis but also causes cell cycle arrest at the G1-S phase in μXg.</p>
              </sec>
              <sec id="sec3dot5-ijms-21-06971">
                <title>3.5. 4-AAQB Inhibition of RANKL-induced Osteoclastogenesis through an Autophagy-Dependent Pathway Under μXg Conditions</title>
                <p>In addition to cell apoptosis and cell cycle arrest, 4-AAQB significantly decreased the protein levels of LC3B-II/LC3B-I and p62 while minimal change was observed in Atg5 and Atg7 (<xref ref-type="fig" rid="ijms-21-06971-f006">Figure 6</xref>A–E). These findings imply that 4-AAQB regulates osteoclastogenesis through an autophagy-dependent pathway. To confirm this, the autophagy inhibitors 3-MA and chloroquine (CQ) were used in subsequent experiments. The results of TRAP staining (<xref ref-type="fig" rid="ijms-21-06971-f006">Figure 6</xref>H–J) and actin ring immunofluorescence (<xref ref-type="fig" rid="ijms-21-06971-f006">Figure 6</xref>K,L) showed that both 3-MA and CQ attenuated osteoclast formation. Both 3-MA and CQ suppressed osteoclastogenesis-related signaling pathway protein markers (<xref ref-type="fig" rid="ijms-21-06971-f006">Figure 6</xref>M–P). These findings indicate that 4-AAQB inhibits μXg-induced osteoclastogenesis through an autophagy-dependent pathway.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="sec4-ijms-21-06971">
              <title>4. Discussion</title>
              <p>4-AAQB, a bioactive compound from <italic>Antrodia cinnamomea</italic>, has shown anti-inflammatory and anti-hepatoma activities [<xref rid="B26-ijms-21-06971" ref-type="bibr">26</xref>]. The present study aimed to investigate the inhibitory effects of 4-AAQB on osteoclastogenesis in both v-Xg and μXg conditions. We found that 4-AAQB alleviated osteoclast formation and function in both environments while 4-AAQB exerted a greater protective effect in μXg than in v-Xg. We further investigated the mechanistic impact of 4-AAQB under μXg conditions. 4-AAQB activated osteoclast apoptosis and caused cell cycle arrest accompanied by autophagy suppression (<xref ref-type="fig" rid="ijms-21-06971-f007">Figure 7</xref>). These results suggest that 4-AAQB inhibits osteoclastogenesis by regulating the autophagy pathway.</p>
              <p>Excessive osteoclastogenesis is exhibited in μXg conditions [<xref rid="B38-ijms-21-06971" ref-type="bibr">38</xref>,<xref rid="B39-ijms-21-06971" ref-type="bibr">39</xref>]; this is the main reason for μXg-induced bone loss. Our study is the first to investigate the regulatory effects of 4-AAQB on osteoclastogenesis in both v-Xg and μXg conditions. We found that the effects of 4-AAQB in v-Xg were similar to those of ALN; however, in µXg, 4-AAQB performed more effectively than ALN. Our findings indicate that 4-AAQB exerted a better protective effect than ALN under μXg conditions, implying a potential role of 4-AAQB in μXg-induced bone loss. These results provide a basis for exploring the beneficial effects of 4-AAQB in vivo. The chemical structure of 4-AAQB is similar to coenzyme Q10 (CoQ10) [<xref rid="B40-ijms-21-06971" ref-type="bibr">40</xref>]. Studies have shown that CoQ10 inhibits osteoclast differentiation by suppressing inflammatory responses, reactive oxygen species generation, and TRAP expression in vitro and in vivo [<xref rid="B22-ijms-21-06971" ref-type="bibr">22</xref>,<xref rid="B41-ijms-21-06971" ref-type="bibr">41</xref>]. In addition, CoQ10 induces the proliferation and differentiation of osteoblasts [<xref rid="B42-ijms-21-06971" ref-type="bibr">42</xref>]. 4-AAQB might show similar mechanisms of action as CoQ10 in osteoblasts. However, this requires further investigation.</p>
              <p>Targeting osteoclast apoptosis is a promising strategy for anti-osteoclastogenesis [<xref rid="B43-ijms-21-06971" ref-type="bibr">43</xref>,<xref rid="B44-ijms-21-06971" ref-type="bibr">44</xref>]. In addition to apoptosis, p21 controls cyclin-dependent kinases [<xref rid="B45-ijms-21-06971" ref-type="bibr">45</xref>]. Cyclin D3 and cyclin E regulate the downstream pathways involved in osteoclast differentiation [<xref rid="B46-ijms-21-06971" ref-type="bibr">46</xref>]. In our study, we showed that 4-AAQB activated apoptosis and caused cell cycle arrest at the G1-S phase, which is similar to the ALN mechanism [<xref rid="B47-ijms-21-06971" ref-type="bibr">47</xref>,<xref rid="B48-ijms-21-06971" ref-type="bibr">48</xref>]. Based on our findings, we suggest that 4-AAQB attenuates osteoclastogenesis by inducing cell apoptosis and causing cell cycle arrest at the G1-S phase. Interestingly, cell apoptosis is related to the autophagy pathway [<xref rid="B32-ijms-21-06971" ref-type="bibr">32</xref>]. μXg has been reported to induce autophagy in pre-osteoclast RAW264.7 cells [<xref rid="B49-ijms-21-06971" ref-type="bibr">49</xref>], which exerts a significant effect on osteoclast differentiation and function [<xref rid="B50-ijms-21-06971" ref-type="bibr">50</xref>]. We showed that 4-AAQB suppressed autophagic flux in RANKL-treated cells, which is consistent with the findings of a previous study [<xref rid="B27-ijms-21-06971" ref-type="bibr">27</xref>]. In addition, autophagy inhibitors 3-MA and CQ showed similar effects. These findings suggest that 4-AAQB attenuates osteoclast differentiation by suppressing autophagic flux. Autophagy also regulates osteoclast apoptosis [<xref rid="B32-ijms-21-06971" ref-type="bibr">32</xref>] and cell cycle in osteoclast progenitors [<xref rid="B51-ijms-21-06971" ref-type="bibr">51</xref>]. Combined with the results of apoptosis and cell cycle arrest, we suggest that 4-AAQB attenuates osteoclastogenesis primarily by inhibiting the autophagy pathway. It subsequently activates cell apoptosis and causes cell cycle arrest to alleviate osteoclast differentiation. Furthermore, in previous studies, autophagy was found to regulate cell apoptosis [<xref rid="B52-ijms-21-06971" ref-type="bibr">52</xref>] and the cell cycle [<xref rid="B53-ijms-21-06971" ref-type="bibr">53</xref>]. These signaling pathways have also been reported to participate in osteoclastogenesis [<xref rid="B47-ijms-21-06971" ref-type="bibr">47</xref>,<xref rid="B54-ijms-21-06971" ref-type="bibr">54</xref>]. Therefore, we concluded that 4-AAQB inhibits osteoclast differentiation by regulating autophagy to impact cell apoptosis and the cell cycle. Our findings were collected in simulated μXg conditions, not a real space environment, which is a limitation of this study. However, our results regarding the molecular mechanisms of 4-AAQB may be applied to understanding the space-induced bone loss of astronauts in the future.</p>
            </sec>
            <sec sec-type="conclusions" id="sec5-ijms-21-06971">
              <title>5. Conclusions</title>
              <p>4-AAQB attenuated μXg-induced osteoclastogenesis by suppressing autophagy, inducing apoptosis, and causing cell cycle arrest at the G1-S phase. Thus, we suggest that 4-AAQB may serve as a potential agent against μXg-induced osteoclast formation.</p>
            </sec>
          </body>
          <back>
            <ack>
              <title>Acknowledgments</title>
              <p>The authors would like to thank the financial support from the Ministry of Science and Technology (MOST 108-2320-B-016-008-MY3 to S.-Y.L.) and the Cheng Hsin General Hospital (CH-NDMC-108-1 to S.-Y.L.) Taipei, Taiwan.</p>
            </ack>
            <notes>
              <title>Author Contributions</title>
              <p>Conceptualization, C.-H.O. and S.-Y.L.; Data curation, C.-H.W.; Formal analysis, C.-H.O. and C.-H.W.; Funding acquisition, C.-H.O. and S.-Y.L.; Investigation, C.-H.W. and I.-C.Y.; Methodology, I.-C.Y. and C.-H.W.; Resources, C.-H.O.; Supervision, S.-Y.L.; Writing—original draft, C.-H.W. and C.-H.O.; Writing—review &amp; editing, S.-Y.L. All authors have read and agreed to the published version of the manuscript.</p>
            </notes>
            <notes>
              <title>Funding</title>
              <p>This work was supported by Grants from the Ministry of Science and Technology (MOST 108-2320-B-016-008-MY3 to S.-Y.L.) and the Cheng Hsin General Hospital (CH-NDMC-108-1 to S.-Y.L.) Taipei, Taiwan.</p>
            </notes>
            <notes notes-type="COI-statement">
              <title>Conflicts of Interest</title>
              <p>The authors declare no conflict of interest associated with this manuscript</p>
            </notes>
            <ref-list>
              <title>References</title>
              <ref id="B1-ijms-21-06971">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Blaber</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Marcal</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Burns</surname>
                      <given-names>B.P.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bioastronautics: The influence of microgravity on astronaut health</article-title>
                  <source>Astrobiology</source>
                  <year>2010</year>
                  <volume>10</volume>
                  <fpage>463</fpage>
                  <lpage>473</lpage>
                  <pub-id pub-id-type="doi">10.1089/ast.2009.0415</pub-id>
                  <?supplied-pmid 20624055?>
                  <pub-id pub-id-type="pmid">20624055</pub-id>
                </element-citation>
              </ref>
              <ref id="B2-ijms-21-06971">
                <label>2.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Charles</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Christophe</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sandrine</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Pierre</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Lapiere</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Betty</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <source>Gravitational and Space Biology Bulletin</source>
                  <publisher-name>American Society for Gravitational and Space Biology</publisher-name>
                  <publisher-loc>New Orleans, LA, USA</publisher-loc>
                  <year>2003</year>
                </element-citation>
              </ref>
              <ref id="B3-ijms-21-06971">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Vernikos</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>V.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Space, gravity and the physiology of aging: Parallel or convergent disciplines? A mini-review</article-title>
                  <source>Gerontology</source>
                  <year>2010</year>
                  <volume>56</volume>
                  <fpage>157</fpage>
                  <lpage>166</lpage>
                  <pub-id pub-id-type="doi">10.1159/000252852</pub-id>
                  <?supplied-pmid 19851058?>
                  <pub-id pub-id-type="pmid">19851058</pub-id>
                </element-citation>
              </ref>
              <ref id="B4-ijms-21-06971">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Barger</surname>
                      <given-names>L.K.</given-names>
                    </name>
                    <name>
                      <surname>Greenleaf</surname>
                      <given-names>J.E.</given-names>
                    </name>
                    <name>
                      <surname>Baldini</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Huff</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of space missions on the human immune system: A meta-analysis</article-title>
                  <source>Sports Med. Train. Rehabil.</source>
                  <year>1995</year>
                  <volume>5</volume>
                  <fpage>293</fpage>
                  <lpage>310</lpage>
                  <pub-id pub-id-type="doi">10.1080/15438629509512026</pub-id>
                </element-citation>
              </ref>
              <ref id="B5-ijms-21-06971">
                <label>5.</label>
                <element-citation publication-type="book">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Dole</surname>
                      <given-names>N.S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Genetic Determinants of Skeletal Diseases: Role of microRNAs</article-title>
                  <source>Ph.D. Thesis</source>
                  <publisher-name>University of Connecticut</publisher-name>
                  <publisher-loc>Mansfield, CT, USA</publisher-loc>
                  <year>2015</year>
                </element-citation>
              </ref>
              <ref id="B6-ijms-21-06971">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lambrecht</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Petersen</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Weerts</surname>
                      <given-names>G.</given-names>
                    </name>
                    <name>
                      <surname>Pruett</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Evetts</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Stokes</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hides</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>The role of physiotherapy in the European Space Agency strategy for preparation and reconditioning of astronauts before and after long duration space flight</article-title>
                  <source>Musculoskelet. Sci. Pract.</source>
                  <year>2017</year>
                  <volume>27</volume>
                  <issue>Suppl. 1</issue>
                  <fpage>S15</fpage>
                  <lpage>S22</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.math.2016.10.009</pub-id>
                  <pub-id pub-id-type="pmid">28173928</pub-id>
                </element-citation>
              </ref>
              <ref id="B7-ijms-21-06971">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ontiveros</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>McCabe</surname>
                      <given-names>L.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation</article-title>
                  <source>J. Cell. Biochem.</source>
                  <year>2003</year>
                  <volume>88</volume>
                  <fpage>427</fpage>
                  <lpage>437</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.10410</pub-id>
                  <?supplied-pmid 12532319?>
                  <pub-id pub-id-type="pmid">12532319</pub-id>
                </element-citation>
              </ref>
              <ref id="B8-ijms-21-06971">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ethiraj</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Link</surname>
                      <given-names>J.R.</given-names>
                    </name>
                    <name>
                      <surname>Sinkway</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Brown</surname>
                      <given-names>G.D.</given-names>
                    </name>
                    <name>
                      <surname>Parler</surname>
                      <given-names>W.A.</given-names>
                    </name>
                    <name>
                      <surname>Reddy</surname>
                      <given-names>S.V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Microgravity modulation of syncytin-A expression enhance osteoclast formation</article-title>
                  <source>J. Cell Biochem.</source>
                  <year>2018</year>
                  <volume>119</volume>
                  <fpage>5696</fpage>
                  <lpage>5703</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.26750</pub-id>
                  <pub-id pub-id-type="pmid">29388695</pub-id>
                </element-citation>
              </ref>
              <ref id="B9-ijms-21-06971">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shanmugarajan</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Moreno-Villanueva</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Clanton</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Rohde</surname>
                      <given-names>L.H.</given-names>
                    </name>
                    <name>
                      <surname>Ramesh</surname>
                      <given-names>G.T.</given-names>
                    </name>
                    <name>
                      <surname>Sibonga</surname>
                      <given-names>J.D.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Combined Effects of Simulated Microgravity and Radiation Exposure on Osteoclast Cell Fusion</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <elocation-id>2443</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms18112443</pub-id>
                </element-citation>
              </ref>
              <ref id="B10-ijms-21-06971">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>D.H.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Hwang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Cha-Molstad</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>K.H.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Inhibition of osteoclasts differentiation by CDC2-induced NFATc1 phosphorylation</article-title>
                  <source>Bone</source>
                  <year>2020</year>
                  <volume>131</volume>
                  <fpage>115153</fpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2019.115153</pub-id>
                  <pub-id pub-id-type="pmid">31730830</pub-id>
                </element-citation>
              </ref>
              <ref id="B11-ijms-21-06971">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pang</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Rodriguez-Gonzalez</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hernandez</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Recinos</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Seldeen</surname>
                      <given-names>K.L.</given-names>
                    </name>
                    <name>
                      <surname>Troen</surname>
                      <given-names>B.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>AP-1 and Mitf interact with NFATc1 to stimulate cathepsin K promoter activity in osteoclast precursors</article-title>
                  <source>J. Cell Biochem.</source>
                  <year>2019</year>
                  <volume>120</volume>
                  <fpage>12382</fpage>
                  <lpage>12392</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcb.28504</pub-id>
                  <pub-id pub-id-type="pmid">30816596</pub-id>
                </element-citation>
              </ref>
              <ref id="B12-ijms-21-06971">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Choi</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yoo</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Bae</surname>
                      <given-names>M.K.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>Y.D.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Connective tissue growth factor (CTGF) regulates the fusion of osteoclast precursors by inhibiting Bcl6 in periodontitis</article-title>
                  <source>Int. J. Med. Sci.</source>
                  <year>2020</year>
                  <volume>17</volume>
                  <fpage>647</fpage>
                  <lpage>656</lpage>
                  <pub-id pub-id-type="doi">10.7150/ijms.41075</pub-id>
                  <pub-id pub-id-type="pmid">32210715</pub-id>
                </element-citation>
              </ref>
              <ref id="B13-ijms-21-06971">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>Z.L.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>Y.L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J.L.</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Q.Y.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>L.X.</given-names>
                    </name>
                    <name>
                      <surname>Wen</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>Y.Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y.R.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>Y.J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Osteoclast stimulatory transmembrane protein (OC-STAMP) is a promising molecular prognostic indicator for multiple myeloma</article-title>
                  <source>Eur. J. Haematol.</source>
                  <year>2020</year>
                  <volume>105</volume>
                  <fpage>185</fpage>
                  <lpage>195</lpage>
                  <pub-id pub-id-type="doi">10.1111/ejh.13425</pub-id>
                  <?supplied-pmid 32282962?>
                  <pub-id pub-id-type="pmid">32282962</pub-id>
                </element-citation>
              </ref>
              <ref id="B14-ijms-21-06971">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wada</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Nakashima</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hiroshi</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Penninger</surname>
                      <given-names>J.M.</given-names>
                    </name>
                  </person-group>
                  <article-title>RANKL-RANK signaling in osteoclastogenesis and bone disease</article-title>
                  <source>Trends Mol. Med.</source>
                  <year>2006</year>
                  <volume>12</volume>
                  <fpage>17</fpage>
                  <lpage>25</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.molmed.2005.11.007</pub-id>
                  <?supplied-pmid 16356770?>
                  <pub-id pub-id-type="pmid">16356770</pub-id>
                </element-citation>
              </ref>
              <ref id="B15-ijms-21-06971">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bi</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Gao</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Xiao</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Dai</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Key Triggers of Osteoclast-Related Diseases and Available Strategies for Targeted Therapies: A Review</article-title>
                  <source>Front. Med.</source>
                  <year>2017</year>
                  <volume>4</volume>
                  <fpage>234</fpage>
                  <pub-id pub-id-type="doi">10.3389/fmed.2017.00234</pub-id>
                  <?supplied-pmid 29326938?>
                  <pub-id pub-id-type="pmid">29326938</pub-id>
                </element-citation>
              </ref>
              <ref id="B16-ijms-21-06971">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yi</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of sodium alendronate on osteoporosis and apoptosis-related factors Cyt C, Apaf-1 and caspase-9</article-title>
                  <source>Biomed. Res.</source>
                  <year>2018</year>
                  <volume>29</volume>
                  <fpage>416</fpage>
                  <lpage>420</lpage>
                  <pub-id pub-id-type="doi">10.4066/biomedicalresearch.29-17-2527</pub-id>
                </element-citation>
              </ref>
              <ref id="B17-ijms-21-06971">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Abe</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Yoshimura</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Deyama</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Kikuiri</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Hasegawa</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Tei</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Shinoda</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Kitagawa</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells</article-title>
                  <source>Int. J. Mol. Med.</source>
                  <year>2012</year>
                  <volume>29</volume>
                  <fpage>1007</fpage>
                  <lpage>1015</lpage>
                  <?supplied-pmid 22447156?>
                  <pub-id pub-id-type="pmid">22447156</pub-id>
                </element-citation>
              </ref>
              <ref id="B18-ijms-21-06971">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xue</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liang</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Fu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Xie</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Ke</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>IL-17A modulates osteoclast precursors’ apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>2019</year>
                  <volume>508</volume>
                  <fpage>1088</fpage>
                  <lpage>1092</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.12.029</pub-id>
                  <pub-id pub-id-type="pmid">30553450</pub-id>
                </element-citation>
              </ref>
              <ref id="B19-ijms-21-06971">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xiu</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Morita</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yao</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Xing</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Boyce</surname>
                      <given-names>B.F.</given-names>
                    </name>
                  </person-group>
                  <article-title>Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation</article-title>
                  <source>J. Clin. Investig.</source>
                  <year>2014</year>
                  <volume>124</volume>
                  <fpage>297</fpage>
                  <lpage>310</lpage>
                  <pub-id pub-id-type="doi">10.1172/JCI66947</pub-id>
                  <pub-id pub-id-type="pmid">24316970</pub-id>
                </element-citation>
              </ref>
              <ref id="B20-ijms-21-06971">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cavanagh</surname>
                      <given-names>P.R.</given-names>
                    </name>
                    <name>
                      <surname>Licata</surname>
                      <given-names>A.A.</given-names>
                    </name>
                    <name>
                      <surname>Rice</surname>
                      <given-names>A.J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Exercise And Pharmacological Countermeasures For Bone Loss During Longduration Space Flight</article-title>
                  <source>Gravit. Space Biol.</source>
                  <year>2005</year>
                  <volume>18</volume>
                  <fpage>39</fpage>
                  <lpage>58</lpage>
                  <pub-id pub-id-type="pmid">16038092</pub-id>
                </element-citation>
              </ref>
              <ref id="B21-ijms-21-06971">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>LeBlanc</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Schneider</surname>
                      <given-names>V.</given-names>
                    </name>
                  </person-group>
                  <article-title>Countermeasures Against Space Flight Related Bone Loss</article-title>
                  <source>Acta Astronaut.</source>
                  <year>1992</year>
                  <volume>27</volume>
                  <fpage>89</fpage>
                  <lpage>92</lpage>
                  <pub-id pub-id-type="doi">10.1016/0094-5765(92)90182-I</pub-id>
                  <pub-id pub-id-type="pmid">11537604</pub-id>
                </element-citation>
              </ref>
              <ref id="B22-ijms-21-06971">
                <label>22.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ikegame</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Hattori</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Tabata</surname>
                      <given-names>M.J.</given-names>
                    </name>
                    <name>
                      <surname>Kitamura</surname>
                      <given-names>K.I.</given-names>
                    </name>
                    <name>
                      <surname>Tabuchi</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Furusawa</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Maruyama</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Yamamoto</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Sekiguchi</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Matsuoka</surname>
                      <given-names>R.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Melatonin is a potential drug for the prevention of bone loss during space flight</article-title>
                  <source>J. Pineal Res.</source>
                  <year>2019</year>
                  <volume>67</volume>
                  <fpage>e12594</fpage>
                  <pub-id pub-id-type="doi">10.1111/jpi.12594</pub-id>
                  <pub-id pub-id-type="pmid">31286565</pub-id>
                </element-citation>
              </ref>
              <ref id="B23-ijms-21-06971">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chang</surname>
                      <given-names>C.H.</given-names>
                    </name>
                    <name>
                      <surname>Hsu</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>A.S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>S.W.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>K.T.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>W.L.</given-names>
                    </name>
                    <name>
                      <surname>Peng</surname>
                      <given-names>H.C.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>C.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>4-Acetylantroquinonol B inhibits lipopolysaccharide-induced cytokine release and alleviates sepsis through of MAPK and NFkappaB suppression</article-title>
                  <source>BMC Complement. Altern. Med.</source>
                  <year>2018</year>
                  <volume>18</volume>
                  <elocation-id>108</elocation-id>
                  <pub-id pub-id-type="doi">10.1186/s12906-018-2172-2</pub-id>
                  <?supplied-pmid 29566694?>
                  <pub-id pub-id-type="pmid">29566694</pub-id>
                </element-citation>
              </ref>
              <ref id="B24-ijms-21-06971">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Li</surname>
                      <given-names>T.-Y.</given-names>
                    </name>
                    <name>
                      <surname>Chiang</surname>
                      <given-names>B.-H.</given-names>
                    </name>
                  </person-group>
                  <article-title>4-Acetylantroquinonol B from antrodia cinnamomea enhances immune function of dendritic cells against liver cancer stem cells</article-title>
                  <source>Biomed. Pharm.</source>
                  <year>2019</year>
                  <volume>109</volume>
                  <fpage>2262</fpage>
                  <lpage>2269</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.biopha.2018.11.101</pub-id>
                  <?supplied-pmid 30551483?>
                  <pub-id pub-id-type="pmid">30551483</pub-id>
                </element-citation>
              </ref>
              <ref id="B25-ijms-21-06971">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lee</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>L.J.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>T.T.</given-names>
                    </name>
                  </person-group>
                  <article-title>Evaluation of potential antioxidant and anti-inflammatory effects of <italic>Antrodia cinnamomea</italic> powder and the underlying molecular mechanisms via Nrf2- and NF-kappaB-dominated pathways in broiler chickens</article-title>
                  <source>Poult Sci.</source>
                  <year>2018</year>
                  <volume>97</volume>
                  <fpage>2419</fpage>
                  <lpage>2434</lpage>
                  <pub-id pub-id-type="doi">10.3382/ps/pey076</pub-id>
                  <?supplied-pmid 29672743?>
                  <pub-id pub-id-type="pmid">29672743</pub-id>
                </element-citation>
              </ref>
              <ref id="B26-ijms-21-06971">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lin</surname>
                      <given-names>Y.W.</given-names>
                    </name>
                    <name>
                      <surname>Pan</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>R.H.</given-names>
                    </name>
                    <name>
                      <surname>Kuo</surname>
                      <given-names>Y.H.</given-names>
                    </name>
                    <name>
                      <surname>Sheen</surname>
                      <given-names>L.Y.</given-names>
                    </name>
                    <name>
                      <surname>Chiang</surname>
                      <given-names>B.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>The 4-acetylantroquinonol B isolated from mycelium of <italic>Antrodia cinnamomea</italic> inhibits proliferation of hepatoma cells</article-title>
                  <source>J. Sci. Food Agric.</source>
                  <year>2010</year>
                  <volume>90</volume>
                  <fpage>1739</fpage>
                  <lpage>1744</lpage>
                  <pub-id pub-id-type="doi">10.1002/jsfa.4010</pub-id>
                  <?supplied-pmid 20564437?>
                  <pub-id pub-id-type="pmid">20564437</pub-id>
                </element-citation>
              </ref>
              <ref id="B27-ijms-21-06971">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Bamodu</surname>
                      <given-names>O.A.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>W.C.</given-names>
                    </name>
                    <name>
                      <surname>Zucha</surname>
                      <given-names>M.A.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Y.K.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>A.T.H.</given-names>
                    </name>
                    <name>
                      <surname>Huang</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>W.H.</given-names>
                    </name>
                    <name>
                      <surname>Yuan</surname>
                      <given-names>C.C.</given-names>
                    </name>
                    <name>
                      <surname>Hsiao</surname>
                      <given-names>M.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway</article-title>
                  <source>Toxicol. Appl. Pharm.</source>
                  <year>2017</year>
                  <volume>325</volume>
                  <fpage>48</fpage>
                  <lpage>60</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.taap.2017.04.003</pub-id>
                </element-citation>
              </ref>
              <ref id="B28-ijms-21-06971">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Yin</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Q.</given-names>
                    </name>
                    <name>
                      <surname>Guo</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Shen</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Wan</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>X.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-kappaB and JNK signaling pathways during osteoporosis treatment</article-title>
                  <source>Biochem. Biophys. Res. Commun.</source>
                  <year>2019</year>
                  <volume>509</volume>
                  <fpage>294</fpage>
                  <lpage>300</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.12.125</pub-id>
                  <pub-id pub-id-type="pmid">30583865</pub-id>
                </element-citation>
              </ref>
              <ref id="B29-ijms-21-06971">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yen</surname>
                      <given-names>I.C.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>K.T.</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>F.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kuo</surname>
                      <given-names>M.T.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>W.L.</given-names>
                    </name>
                  </person-group>
                  <article-title>In Vitro Anticancer Activity and Structural Characterization of Ubiquinones from <italic>Antrodia cinnamomea</italic> Mycelium</article-title>
                  <source>Molecules</source>
                  <year>2017</year>
                  <volume>22</volume>
                  <elocation-id>747</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/molecules22050747</pub-id>
                </element-citation>
              </ref>
              <ref id="B30-ijms-21-06971">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yang</surname>
                      <given-names>S.S.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>G.J.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Y.Y.</given-names>
                    </name>
                    <name>
                      <surname>Kuo</surname>
                      <given-names>Y.H.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>T.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>New constituents with iNOS inhibitory activity from mycelium of Antrodia camphorata</article-title>
                  <source>Planta Med.</source>
                  <year>2009</year>
                  <volume>75</volume>
                  <fpage>512</fpage>
                  <lpage>516</lpage>
                  <pub-id pub-id-type="doi">10.1055/s-0029-1185305</pub-id>
                  <pub-id pub-id-type="pmid">19189245</pub-id>
                </element-citation>
              </ref>
              <ref id="B31-ijms-21-06971">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>K.Y.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>B.</given-names>
                    </name>
                  </person-group>
                  <article-title>Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-kappaB/ERK signaling pathway in Raw264.7 cells</article-title>
                  <source>Phytomed. Int. J. Phytother. Phytopharm.</source>
                  <year>2018</year>
                  <volume>51</volume>
                  <fpage>181</fpage>
                  <lpage>190</lpage>
                </element-citation>
              </ref>
              <ref id="B32-ijms-21-06971">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kim</surname>
                      <given-names>C.J.</given-names>
                    </name>
                    <name>
                      <surname>Shin</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>B.J.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>C.H.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Kang</surname>
                      <given-names>H.M.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>B.S.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>I.R.</given-names>
                    </name>
                  </person-group>
                  <article-title>The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation</article-title>
                  <source>Int. J. Mol. Sci.</source>
                  <year>2018</year>
                  <volume>19</volume>
                  <elocation-id>125</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms19010125</pub-id>
                </element-citation>
              </ref>
              <ref id="B33-ijms-21-06971">
                <label>33.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>W.H.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>L.S.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>T.C.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Antcamphin M Inhibits TLR4-Mediated Inflammatory Responses by Upregulating the Nrf2/HO-1 Pathway and Suppressing the NLRP3 Inflammasome Pathway in Macrophages</article-title>
                  <source>Am. J. Chin. Med.</source>
                  <year>2019</year>
                  <volume>47</volume>
                  <fpage>1611</fpage>
                  <lpage>1626</lpage>
                  <pub-id pub-id-type="doi">10.1142/S0192415X19500824</pub-id>
                  <?supplied-pmid 31645125?>
                  <pub-id pub-id-type="pmid">31645125</pub-id>
                </element-citation>
              </ref>
              <ref id="B34-ijms-21-06971">
                <label>34.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Jia</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Jiang</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Lu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Han</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Qian</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism</article-title>
                  <source>J. Cell Physiol.</source>
                  <year>2019</year>
                  <volume>234</volume>
                  <fpage>7498</fpage>
                  <lpage>7509</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcp.27511</pub-id>
                  <?supplied-pmid 30471112?>
                  <pub-id pub-id-type="pmid">30471112</pub-id>
                </element-citation>
              </ref>
              <ref id="B35-ijms-21-06971">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chaugule</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sureshbabu</surname>
                      <given-names>S.K.</given-names>
                    </name>
                    <name>
                      <surname>Dakave</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Krishna</surname>
                      <given-names>C.M.</given-names>
                    </name>
                    <name>
                      <surname>Chaudhari</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Indap</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Chiplunkar</surname>
                      <given-names>S.</given-names>
                    </name>
                  </person-group>
                  <article-title>Hexane Fraction of Turbo brunneus Inhibits Intermediates of RANK-RANKL Signaling Pathway and Prevent Ovariectomy Induced Bone Loss</article-title>
                  <source>Front. Med.</source>
                  <year>2019</year>
                  <volume>10</volume>
                  <fpage>608</fpage>
                  <pub-id pub-id-type="doi">10.3389/fendo.2019.00608</pub-id>
                  <?supplied-pmid 31555218?>
                  <pub-id pub-id-type="pmid">31555218</pub-id>
                </element-citation>
              </ref>
              <ref id="B36-ijms-21-06971">
                <label>36.</label>
                <element-citation publication-type="web">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rao</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Tan</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Faruqi</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Beltzer</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.corning.com/catalog/cls/documents/application-notes/snappshots_CLS_AN_144_osteo_assay.pdf">https://www.corning.com/catalog/cls/documents/application-notes/snappshots_CLS_AN_144_osteo_assay.pdf</ext-link></comment>
                  <date-in-citation content-type="access-date" iso-8601-date="2020-09-22">(accessed on 22 September 2020)</date-in-citation>
                </element-citation>
              </ref>
              <ref id="B37-ijms-21-06971">
                <label>37.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Yen</surname>
                      <given-names>I.C.</given-names>
                    </name>
                    <name>
                      <surname>Shi</surname>
                      <given-names>L.S.</given-names>
                    </name>
                    <name>
                      <surname>Chung</surname>
                      <given-names>M.C.</given-names>
                    </name>
                    <name>
                      <surname>Ahmetaj-Shala</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>T.C.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Antrolone, a Novel Benzoid Derived from Antrodia cinnamomea, Inhibits the LPS-Induced Inflammatory Response in RAW264.7 Macrophage Cells by Balancing the NF-[Formula: See text]B and Nrf2 Pathways</article-title>
                  <source>Am. J. Chin. Med.</source>
                  <year>2018</year>
                  <volume>46</volume>
                  <fpage>1297</fpage>
                  <lpage>1313</lpage>
                  <pub-id pub-id-type="doi">10.1142/S0192415X18500684</pub-id>
                  <pub-id pub-id-type="pmid">30149752</pub-id>
                </element-citation>
              </ref>
              <ref id="B38-ijms-21-06971">
                <label>38.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chatani</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Mantoku</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Takeyama</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Abduweli</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Sugamori</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Aoki</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Ohya</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Suzuki</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Uchida</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Sakimura</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Microgravity promotes osteoclast activity in medaka fish reared at the international space station</article-title>
                  <source>Sci. Rep.</source>
                  <year>2015</year>
                  <volume>5</volume>
                  <fpage>14172</fpage>
                  <pub-id pub-id-type="doi">10.1038/srep14172</pub-id>
                  <pub-id pub-id-type="pmid">26387549</pub-id>
                </element-citation>
              </ref>
              <ref id="B39-ijms-21-06971">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Nabavi</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Khandani</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Camirand</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Harrison</surname>
                      <given-names>R.E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of microgravity on osteoclast bone resorption and osteoblast cytoskeletal organization and adhesion</article-title>
                  <source>Bone</source>
                  <year>2011</year>
                  <volume>49</volume>
                  <fpage>965</fpage>
                  <lpage>974</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bone.2011.07.036</pub-id>
                  <pub-id pub-id-type="pmid">21839189</pub-id>
                </element-citation>
              </ref>
              <ref id="B40-ijms-21-06971">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chou</surname>
                      <given-names>K.C.</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>H.L.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>P.Y.</given-names>
                    </name>
                    <name>
                      <surname>Chang</surname>
                      <given-names>T.L.</given-names>
                    </name>
                    <name>
                      <surname>Sheu</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>K.H.</given-names>
                    </name>
                    <name>
                      <surname>Chiang</surname>
                      <given-names>B.H.</given-names>
                    </name>
                  </person-group>
                  <article-title>Biosynthesis of Antroquinonol and 4-Acetylantroquinonol B via a Polyketide Pathway Using Orsellinic Acid as a Ring Precursor in Antrodia cinnamomea</article-title>
                  <source>J. Agric. Food Chem.</source>
                  <year>2017</year>
                  <volume>65</volume>
                  <fpage>74</fpage>
                  <lpage>86</lpage>
                  <pub-id pub-id-type="doi">10.1021/acs.jafc.6b04346</pub-id>
                  <pub-id pub-id-type="pmid">28001060</pub-id>
                </element-citation>
              </ref>
              <ref id="B41-ijms-21-06971">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Moon</surname>
                      <given-names>H.J.</given-names>
                    </name>
                    <name>
                      <surname>Ko</surname>
                      <given-names>W.K.</given-names>
                    </name>
                    <name>
                      <surname>Jung</surname>
                      <given-names>M.S.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.H.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>W.J.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>K.S.</given-names>
                    </name>
                    <name>
                      <surname>Heo</surname>
                      <given-names>J.K.</given-names>
                    </name>
                    <name>
                      <surname>Bang</surname>
                      <given-names>J.B.</given-names>
                    </name>
                    <name>
                      <surname>Kwon</surname>
                      <given-names>I.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Coenzyme q10 regulates osteoclast and osteoblast differentiation</article-title>
                  <source>J. Food Sci.</source>
                  <year>2013</year>
                  <volume>78</volume>
                  <fpage>H785</fpage>
                  <lpage>H891</lpage>
                  <pub-id pub-id-type="doi">10.1111/1750-3841.12116</pub-id>
                  <pub-id pub-id-type="pmid">23582186</pub-id>
                </element-citation>
              </ref>
              <ref id="B42-ijms-21-06971">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zheng</surname>
                      <given-names>D.</given-names>
                    </name>
                    <name>
                      <surname>Cui</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yu</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Coenzyme Q10 promotes osteoblast proliferation and differentiation and protects against ovariectomy-induced osteoporosis</article-title>
                  <source>Mol. Med. Rep.</source>
                  <year>2018</year>
                  <volume>17</volume>
                  <fpage>400</fpage>
                  <lpage>407</lpage>
                  <pub-id pub-id-type="doi">10.3892/mmr.2017.7907</pub-id>
                  <pub-id pub-id-type="pmid">29115467</pub-id>
                </element-citation>
              </ref>
              <ref id="B43-ijms-21-06971">
                <label>43.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>McCarthy</surname>
                      <given-names>M.</given-names>
                    </name>
                  </person-group>
                  <article-title>Bones protected by promotion of osteoclast apoptosis</article-title>
                  <source>Lancet</source>
                  <year>1996</year>
                  <volume>348</volume>
                  <fpage>9033</fpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(05)64928-8</pub-id>
                </element-citation>
              </ref>
              <ref id="B44-ijms-21-06971">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Liu</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Xia</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Gu</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Bian</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Yuan</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Z.</given-names>
                    </name>
                  </person-group>
                  <article-title>Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway</article-title>
                  <source>PLoS ONE</source>
                  <year>2015</year>
                  <volume>10</volume>
                  <elocation-id>e0142519</elocation-id>
                  <pub-id pub-id-type="doi">10.1371/journal.pone.0142519</pub-id>
                  <?supplied-pmid 26571489?>
                  <pub-id pub-id-type="pmid">26571489</pub-id>
                </element-citation>
              </ref>
              <ref id="B45-ijms-21-06971">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Harper</surname>
                      <given-names>J.W.</given-names>
                    </name>
                    <name>
                      <surname>Elledge</surname>
                      <given-names>S.J.</given-names>
                    </name>
                    <name>
                      <surname>Keyomarsi</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Dynlacht</surname>
                      <given-names>B.</given-names>
                    </name>
                    <name>
                      <surname>Tsai</surname>
                      <given-names>L.H.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Dobrowolski</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Bai</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Connell-Crowley</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Swindell</surname>
                      <given-names>E.</given-names>
                    </name>
                  </person-group>
                  <article-title>Inhibition of Cyclin-dependent Kinases by p21</article-title>
                  <source>Mol. Biol. Cell.</source>
                  <year>1995</year>
                  <volume>6</volume>
                  <fpage>387</fpage>
                  <lpage>400</lpage>
                  <pub-id pub-id-type="doi">10.1091/mbc.6.4.387</pub-id>
                  <?supplied-pmid 7626805?>
                  <pub-id pub-id-type="pmid">7626805</pub-id>
                </element-citation>
              </ref>
              <ref id="B46-ijms-21-06971">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bossy</surname>
                      <given-names>E.</given-names>
                    </name>
                    <name>
                      <surname>Talmant</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Peyrin</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Akrout</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Cloetens</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Laugier</surname>
                      <given-names>P.</given-names>
                    </name>
                  </person-group>
                  <article-title>An in vitro study of the ultrasonic axial transmission technique at the radius: 1-MHz velocity measurements are sensitive to both mineralization and intracortical porosity</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2004</year>
                  <volume>19</volume>
                  <fpage>1548</fpage>
                  <lpage>1556</lpage>
                  <pub-id pub-id-type="doi">10.1359/JBMR.040513</pub-id>
                  <?supplied-pmid 15312257?>
                  <pub-id pub-id-type="pmid">15312257</pub-id>
                </element-citation>
              </ref>
              <ref id="B47-ijms-21-06971">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ding</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Yao</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Bai</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Cheng</surname>
                      <given-names>P.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Mei</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Xing</surname>
                      <given-names>J.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Alendronate induces osteoclast precursor apoptosis via peroxisomal dysfunction mediated ER stress</article-title>
                  <source>J. Cell Physiol.</source>
                  <year>2018</year>
                  <volume>233</volume>
                  <fpage>7415</fpage>
                  <lpage>7423</lpage>
                  <pub-id pub-id-type="doi">10.1002/jcp.26587</pub-id>
                  <?supplied-pmid 29600563?>
                  <pub-id pub-id-type="pmid">29600563</pub-id>
                </element-citation>
              </ref>
              <ref id="B48-ijms-21-06971">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kusamori</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Katsumi</surname>
                      <given-names>H.</given-names>
                    </name>
                    <name>
                      <surname>Abe</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Ueda</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Sakai</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hayashi</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Hirai</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Quan</surname>
                      <given-names>Y.S.</given-names>
                    </name>
                    <name>
                      <surname>Kamiyama</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Sakane</surname>
                      <given-names>T.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis</article-title>
                  <source>J. Bone Miner. Res.</source>
                  <year>2010</year>
                  <volume>25</volume>
                  <fpage>2582</fpage>
                  <lpage>2591</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbmr.147</pub-id>
                  <pub-id pub-id-type="pmid">20533374</pub-id>
                </element-citation>
              </ref>
              <ref id="B49-ijms-21-06971">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ryu</surname>
                      <given-names>H.W.</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>S.H.</given-names>
                    </name>
                    <name>
                      <surname>Namkoong</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Jang</surname>
                      <given-names>I.S.</given-names>
                    </name>
                    <name>
                      <surname>Seo</surname>
                      <given-names>D.H.</given-names>
                    </name>
                    <name>
                      <surname>Choi</surname>
                      <given-names>I.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>J.</given-names>
                    </name>
                  </person-group>
                  <article-title>Simulated microgravity contributes to autophagy induction by regulating AMP-activated protein kinase</article-title>
                  <source>DNA Cell Biol.</source>
                  <year>2014</year>
                  <volume>33</volume>
                  <fpage>128</fpage>
                  <lpage>135</lpage>
                  <pub-id pub-id-type="doi">10.1089/dna.2013.2089</pub-id>
                  <pub-id pub-id-type="pmid">24387300</pub-id>
                </element-citation>
              </ref>
              <ref id="B50-ijms-21-06971">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Shapiro</surname>
                      <given-names>I.M.</given-names>
                    </name>
                    <name>
                      <surname>Layfield</surname>
                      <given-names>R.</given-names>
                    </name>
                    <name>
                      <surname>Lotz</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Settembre</surname>
                      <given-names>C.</given-names>
                    </name>
                    <name>
                      <surname>Whitehouse</surname>
                      <given-names>C.</given-names>
                    </name>
                  </person-group>
                  <article-title>Boning up on autophagy: The role of autophagy in skeletal biology</article-title>
                  <source>Autophagy</source>
                  <year>2014</year>
                  <volume>10</volume>
                  <fpage>7</fpage>
                  <lpage>19</lpage>
                  <pub-id pub-id-type="doi">10.4161/auto.26679</pub-id>
                  <pub-id pub-id-type="pmid">24225636</pub-id>
                </element-citation>
              </ref>
              <ref id="B51-ijms-21-06971">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cao</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>A.</given-names>
                    </name>
                    <name>
                      <surname>Cai</surname>
                      <given-names>J.</given-names>
                    </name>
                    <name>
                      <surname>Yuan</surname>
                      <given-names>N.</given-names>
                    </name>
                    <name>
                      <surname>Lin</surname>
                      <given-names>W.</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>S.</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>F.</given-names>
                    </name>
                    <name>
                      <surname>Song</surname>
                      <given-names>L.</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>X.</given-names>
                    </name>
                    <name>
                      <surname>Fang</surname>
                      <given-names>Y.</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Autophagy regulates the cell cycle of murine HSPCs in a nutrient-dependent manner</article-title>
                  <source>Exp. Hematol.</source>
                  <year>2015</year>
                  <volume>43</volume>
                  <fpage>229</fpage>
                  <lpage>242</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.exphem.2014.11.002</pub-id>
                  <?supplied-pmid 25461254?>
                  <pub-id pub-id-type="pmid">25461254</pub-id>
                </element-citation>
              </ref>
              <ref id="B52-ijms-21-06971">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>S.P.</given-names>
                    </name>
                    <name>
                      <surname>Chien</surname>
                      <given-names>J.Y.</given-names>
                    </name>
                    <name>
                      <surname>Tsai</surname>
                      <given-names>R.K.</given-names>
                    </name>
                  </person-group>
                  <article-title>Ethambutol induces impaired autophagic flux and apoptosis in the rat retina</article-title>
                  <source>Dis Model. Mech.</source>
                  <year>2015</year>
                  <volume>8</volume>
                  <fpage>977</fpage>
                  <lpage>987</lpage>
                  <pub-id pub-id-type="doi">10.1242/dmm.019737</pub-id>
                  <pub-id pub-id-type="pmid">26092127</pub-id>
                </element-citation>
              </ref>
              <ref id="B53-ijms-21-06971">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zheng</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>Z.</given-names>
                    </name>
                    <name>
                      <surname>Kitazato</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Y.</given-names>
                    </name>
                  </person-group>
                  <article-title>Selective Autophagy Regulates Cell Cycle in Cancer Therapy</article-title>
                  <source>Theranostics</source>
                  <year>2019</year>
                  <volume>9</volume>
                  <fpage>104</fpage>
                  <lpage>125</lpage>
                  <pub-id pub-id-type="doi">10.7150/thno.30308</pub-id>
                  <?supplied-pmid 30662557?>
                  <pub-id pub-id-type="pmid">30662557</pub-id>
                </element-citation>
              </ref>
              <ref id="B54-ijms-21-06971">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kwon</surname>
                      <given-names>M.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>J.M.</given-names>
                    </name>
                    <name>
                      <surname>Lee</surname>
                      <given-names>K.</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>S.Y.</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>H.S.</given-names>
                    </name>
                    <name>
                      <surname>Kim</surname>
                      <given-names>T.</given-names>
                    </name>
                    <name>
                      <surname>Jeong</surname>
                      <given-names>D.</given-names>
                    </name>
                  </person-group>
                  <article-title>Synchronized Cell Cycle Arrest Promotes Osteoclast Differentiation</article-title>
                  <source>Int J. Mol. Sci.</source>
                  <year>2016</year>
                  <volume>17</volume>
                  <elocation-id>1292</elocation-id>
                  <pub-id pub-id-type="doi">10.3390/ijms17081292</pub-id>
                  <?supplied-pmid 27517906?>
                  <pub-id pub-id-type="pmid">27517906</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
          <floats-group>
            <fig id="ijms-21-06971-f001" orientation="portrait" position="float">
              <label>Figure 1</label>
              <caption>
                <p>Effects of 4-AAQB on RAW264.7 cell viability. Chemical structure of 4-AAQB (<bold>A</bold>). Cell viability was assayed by alamarBlue for 2 h after cell stimulation with v-Xg or µXg for 24 h (<bold>B</bold>). The quantitative results are presented as the mean ± SEM (<italic>n</italic> = 3).</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g001"/>
            </fig>
            <fig id="ijms-21-06971-f002" orientation="portrait" position="float">
              <label>Figure 2</label>
              <caption>
                <p>4-AAQB attenuation of osteoclast formation after v-Xg and µXg stimulation. After exposure in v-Xg (<bold>A</bold>) or µXg (<bold>B</bold>) for 24 h, and the cells were treated with 4-AAQB (0.1, 1, 3, or 10 µM) or ALN (10 µM) combined with RANKL for 72 h. The quantitative results of the number of TRAP (+) osteoclasts/well (<bold>C</bold>) and area of TRAP (+) osteoclasts (%) (<bold>D</bold>) represent the mean ± SEM (<italic>n</italic> = 6). In addition, fluorescent staining (actin ring and DAPI; (<bold>E</bold>,<bold>F</bold>)) and quantitative results (number of actin rings/well; (<bold>G</bold>)) were conducted. Osteoclasts or actin rings are indicated by red arrows. Orange rectangles represent the areas magnified 200 times. *** <italic>p</italic> &lt; 0.001 versus control; # <italic>p</italic> &lt; 0.05, ## <italic>p</italic> &lt; 0.01, and ### <italic>p</italic> &lt; 0.001 versus RANKL; ++ <italic>p</italic> &lt; 0.01 and +++ <italic>p</italic> &lt; 0.001 versus v-Xg.</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g002a"/>
              <graphic xlink:href="ijms-21-06971-g002b"/>
              <graphic xlink:href="ijms-21-06971-g002c"/>
            </fig>
            <fig id="ijms-21-06971-f003" orientation="portrait" position="float">
              <label>Figure 3</label>
              <caption>
                <p>4-AAQB attenuation of osteoclast resorption ability after v-Xg and µXg stimulation. After exposure in v-Xg (<bold>A</bold>) or µXg (<bold>B</bold>) for 24 h, and the cells were cultured in osteo assay 96-well plates and treated with 4-AAQB (0.1, 1, 3, or 10 µM) or ALN (10 µM) combined with RANKL for 120 h. The bone resorption area (%) (<bold>C</bold>) quantitative results represent the mean ± SEM (n = 4). White arrows indicate the resorption pits. *** <italic>p</italic> &lt; 0.001 versus control; # <italic>p</italic> &lt; 0.05, ## <italic>p</italic> &lt; 0.01, and ### <italic>p</italic> &lt; 0.001 versus RANKL; ++ <italic>p</italic> &lt; 0.01 versus v-Xg.</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g003"/>
            </fig>
            <fig id="ijms-21-06971-f004" orientation="portrait" position="float">
              <label>Figure 4</label>
              <caption>
                <p>Effects of 4-AAQB on the osteoclastogenesis signaling pathway. Osteoclastogenesis proteins were assayed by western blotting after exposure to v-Xg (<bold>A</bold>) conditions for 24 h. The cells were treated with 4-AAQB (1, 3, or 10 µM) or ALN (10 µM) combined with RANKL for 54 h. The quantitative results of NFATc1 (<bold>B</bold>), c-Fos (<bold>C</bold>), and DC-STAMP (D) represent the mean ± SEM (n = 3). In addition, after exposure to μXg (<bold>E</bold>) conditions for 24 h, the cells were treated under the same stimulation conditions as the v-Xg group for 48 h. The quantitative results (<bold>F</bold>–<bold>H</bold>) represent the mean ± SEM (n = 3). * <italic>p</italic> &lt; 0.05, <sup>**</sup><italic>p</italic> &lt; 0.01 and *** <italic>p</italic> &lt; 0.001 versus control; # <italic>p</italic> &lt; 0.05, ## <italic>p</italic> &lt; 0.01, and ### <italic>p</italic> &lt; 0.001 versus RANKL.</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g004a"/>
              <graphic xlink:href="ijms-21-06971-g004b"/>
            </fig>
            <fig id="ijms-21-06971-f005" orientation="portrait" position="float">
              <label>Figure 5</label>
              <caption>
                <p>Effects of 4-AAQB on osteoclast apoptosis and the cell cycle after μXg stimulation. After exposure to μXg (<bold>A</bold>) conditions for 24 h, the cells were treated with 4-AAQB or ALN combined with RANKL for 48 h. Apoptotic proteins were assayed by western blotting. The quantitative results of cleaved PARP (<bold>B</bold>), cleaved caspase-8 (<bold>C</bold>), cleaved caspase-9 (<bold>D</bold>), and cleaved caspase-3 (<bold>E</bold>) represent the mean ± SEM (n = 3). In addition, the cell cycle proteins were also assayed by western blotting (<bold>F</bold>). The quantitative results of p53 (<bold>G</bold>), p21 (<bold>H</bold>), cyclin D3 (<bold>I</bold>), and cyclin E1 (<bold>J</bold>) represent the mean ± SEM (n = 3). * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, and *** <italic>p</italic> &lt; 0.001 versus control; # <italic>p</italic> &lt; 0.05, ## <italic>p</italic> &lt; 0.01, and ### <italic>p</italic> &lt; 0.001 versus RANKL.</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g005a"/>
              <graphic xlink:href="ijms-21-06971-g005b"/>
            </fig>
            <fig id="ijms-21-06971-f006" orientation="portrait" position="float">
              <label>Figure 6</label>
              <caption>
                <p>Autophagy inhibitor attenuation of osteoclast formation after µXg stimulation. Autophagy proteins were assayed by western blotting (<bold>A</bold>)<bold>.</bold> The quantitative results of LC3B-II/LC3B-I (<bold>B</bold>), p62 (<bold>C</bold>), Atg 7 (<bold>D</bold>), and Atg 5 (<bold>E</bold>) represent the mean ± SEM (<italic>n</italic> = 3). Cell viability was assayed by alamarBlue for 2 h after cell stimulation under µXg conditions for 24 h; stimulation by 3-MA (<bold>F</bold>) or CQ (<bold>G</bold>) continued for 72 h. The quantitative results represent the mean ± SEM (n = 3). TRAP staining was performed after cell stimulation under µXg (<bold>H</bold>) conditions for 24 h. and the cells treated with 4-AAQB (10 µM), 3-MA (1 mM), or CQ (10 µM) combined with RANKL for 72 h. The quantitative results of the number of TRAP (+) osteoclasts/well (<bold>I</bold>) and area of TRAP (+) osteoclasts (%) (<bold>J</bold>) represent the mean ± SEM (<italic>n</italic> = 6). Fluorescent staining was performed after stimulation under µXg (<bold>K</bold>) conditions for 24 h, and the cells treated with 4-AAQB, 3-MA, or CQ combined with RANKL for 72 h. The quantitative results of the number of actin rings/well (<bold>L</bold>) represent the mean ± SEM (n = 4). After exposure to μXg (<bold>M</bold>) conditions for 24 h, the cells were treated with 4-AAQB, 3-MA, or CQ combined with RANKL for 48 h. Osteoclastogenesis proteins were assayed by western blotting. The quantitative results of NFATc1 (<bold>N</bold>), c-Fos (<bold>O</bold>), and DC-STAMP (<bold>P</bold>) represent the mean ± SEM (n = 3). Osteoclasts or actin rings are indicated by red arrows. Orange rectangles represent the areas magnified 200 times. * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, and *** <italic>p</italic> &lt; 0.001 versus control; # <italic>p</italic> &lt; 0.05, ## <italic>p</italic> &lt; 0.01, and ### <italic>p</italic> &lt; 0.001 versus RANKL.</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g006a"/>
              <graphic xlink:href="ijms-21-06971-g006b"/>
            </fig>
            <fig id="ijms-21-06971-f007" orientation="portrait" position="float">
              <label>Figure 7</label>
              <caption>
                <p>Proposed mechanisms of 4-AAQB in osteoclastogenesis.</p>
              </caption>
              <graphic xlink:href="ijms-21-06971-g007"/>
            </fig>
          </floats-group>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
